Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$0.5248 -4.58%
Market Cap
$32.4M
Price Target
Refer to Report
Volume
73.0K
52wk Range
$0.451 - $1.79
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.